Fevertree Drinks remains an attractive premium mixer brand, trading at a reasonable valuation after past volatility and a strong net cash position. Margin expansion, robust free cash flow, and aggressive share buybacks support FQVTF's investment case, despite temporary headwinds from the Molson Coors partnership. The Molson Coors deal enhances U.S. distribution and onshores production, promising long-term cost savings and revenue growth for FQVTF.
Fevertree Drinks Plc said it is trading in line with expectations, in a statement ahead of today's annual general meeting. The tonic and mixer maker forecasts low single-digit revenue growth and an adjusted EBITDA margin of around 12% for its financial year.
Fevertree Drinks PLC has issued £71 million worth of shares to Molson Coors after the duo penned an agreement for its carbonated mixer brand in the US. Some 10,856,628 ordinary shares were issued at a price of 654.2p each, Fevertree said Wednesday, equating to 8.5% of the company.
| Beverages Industry | Consumer Staples Sector | Mr. Timothy Daniel Gray Warrillow CEO | OTC PINK Exchange | GB00BRJ9BJ26 ISIN |
| GB Country | 380 Employees | 16 May 2025 Last Dividend | - Last Split | - IPO Date |
Fevertree Drinks Plc, operating extensively both in the United Kingdom and internationally, specializes in crafting premium mixer drinks. Founded in 2004 with its headquarters in London, United Kingdom, Fevertree has carved a niche for itself in the beverage industry through innovation and quality. Initially known as Fevertree Topco Limited, the company underwent a name change in October 2014 to its current identity, better reflecting its brand ethos and product offerings. It positions itself prominently in the market by supplying an exceptional range of mixer drinks to bars, restaurants, and consumers who seek sophistication and superior taste in their beverages.